Trauma-Informed Approaches Toolkit
Review of the basics of trauma and modules on trauma-informed approaches in the delivery of HIV care.
Resource updated 11/07/2023
Review of the basics of trauma and modules on trauma-informed approaches in the delivery of HIV care.
Resource updated 11/07/2023
This report highlights projects found to offer highly effective (and replicable) approaches to integrating buprenorphine-based medication-assisted treatment into HIV/AIDS primary care. Chapters outline the processes programs need to put in place, including meeting DATA 2000 regulatory requirements, achieving institutional buy-in, implementing staff training requirements, and evaluating processes and outcomes.
Resource updated 04/02/2024
Informational updated 04/03/2024
The purpose of this curriculum is to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
It provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Resource updated 03/12/2024
Overview of training manual on integrating buprenorphine treatment into HIV primary care.
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Resource updated 05/15/2024
Review of how trauma-informed care services were implemented in a medical clinic and community organization, health department implementation actions, and client perspectives on these services.
Resource updated 11/07/2023
Insights on ways that HIV care programs have improved health outcomes along the HIV care continuum.
Resource updated 03/13/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
Review of how RWHAP Part B programs develop, maintain, and evaluate service standards for all funded services, per Policy Clarification Notice (PCN) 16-02.
Resource updated 09/14/2023